At any given time, about half of people with ulcerative colitis (UC) are in remission (a period of no symptoms), according to the Crohn’s and Colitis Foundation. A big part of that success can be attributed to the improvement of treatment options for UC.
One of the newer and remarkable treatment options is biologic therapy. Biologics get their name because they are made from natural life materials, as opposed to chemicals. Compared to other medications for inflammatory bowel diseases, biologics are able to target causes of inflammation more precisely.
Dr. Linden is a gastroenterologist based in New York City and a clinical instructor in the Department of Medicine at NYU Langone Health.
References
American College of Gastroenterology. (n.d.). Ulcerative colitis.
Crohn’s and Colitis Foundation. (2018). Fact sheet: News from the IBD Help Center — biologics.
MedlinePlus. (2016). Ulcerative colitis.
Park S.C., et al. (2015). Current and emerging biologics for ulcerative colitis. Cut and Liver.
Peppercorn, M.A. (2023). Patient education: Ulcerative colitis (beyond the basics). UpToDate.
Testa, A. (2017). Adherence in ulcerative colitis: An overview. Patient Preference and Adherence.
Why trust our experts?











